CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 13,340	$ 27,022	$ 60,761	$ 74,238
General and administrative	6,448	6,897	20,875	19,607
Total operating expenses	19,788	33,919	81,636	93,845
Loss from operations	(19,788)	(33,919)	(81,636)	(93,845)
Other income, net	1,356	2,548	5,020	7,923
Net loss	(18,432)	(31,371)	(76,616)	(85,922)
Other comprehensive income (loss):
Foreign currency translation loss	0	0	0	(655)
Unrealized gain on marketable securities	154	59	4	560
Total comprehensive loss	$ (18,278)	$ (31,312)	$ (76,612)	$ (86,017)
Net loss per share, basic	$ (0.47)	$ (0.82)	$ (1.97)	$ (2.24)
Net loss per share, diluted	$ (0.47)	$ (0.82)	$ (1.97)	$ (2.24)
Weighted average number of shares used in computing net loss per share, basic	38,903,476	38,358,032	38,800,528	38,322,773
Weighted average number of shares used in computing net loss per share, diluted	38,903,476	38,358,032	38,800,528	38,322,773